Findings

What do systematic reviews say?

1,271 questions · 1,326 findings · 329 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 247 · 18.6%GRADE not reported 237 · 17.9%Very low 379 · 28.6%Low 285 · 21.5%Moderate 141 · 10.6%High 37 · 2.8%

NaoXinTong vs 'no treatment'

Adverse events (AEs) (1 or more events) · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

YinDanXingNaoTong vs 'no treatment'

Adverse events (AEs) (1 or more events) · People with vascular dementia

YinDanXingNaoTong showed no clear difference in adverse events (AEs) (1 or more events) compared with 'no treatment' (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
RD 0
2 studies · 138 participants
Low

FuFangHaiShe vs Western medicine

AE (1 or more events) · People with vascular dementia

It is very uncertain whether fuFangHaiShe changes AE (1 or more events) compared with western medicine (very low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 143 participants
Very low

NaoMaiTai vs Western medicine

Adverse events (AEs) (1 or more events) · People with vascular dementia

It is very uncertain whether naoMaiTai changes adverse events (AEs) (1 or more events) compared with western medicine (very low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
RD 0.02
4 studies · 277 participants
Very low

NaoXinTong vs Western medicine

Adverse events (AEs) (1 or more events) · People with vascular dementia

NaoXinTong showed no clear difference in adverse events (AEs) (1 or more events) compared with western medicine (moderate certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 515 participants
Moderate

FuFangDanShen vs 'no treatment'

Adverse events (AEs) (1 or more events) · People with vascular dementia

FuFangDanShen showed no clear difference in adverse events (AEs) (1 or more) compared with 'no treatment' (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
RD 0.02
3 studies · 322 participants
Low

QingKaiLing vs Western medicine

Adverse events (AEs) (1 or more events) · People with vascular dementia

The review found no eligible studies for this question.

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ShenFuTang vs Western medicine

Adverse events (AEs) (1 or more events) · People with vascular dementia

ShenFuTang showed no clear difference in adverse events (AEs) (1 or more events) compared with western medicine (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 166 participants
Low

TongXingLuo vs Western medicine

Adverse events (AEs) (1 or more events) · People with vascular dementia

TongXingLuo showed no clear difference in adverse events (AEs) (1 or more) compared with western medicine (low certainty).

1 finding from 1 review

Traditional Chinese herbal medicine for vascular dementia 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 180 participants
Low

Intervention not reported

Total sleep time Participant reports. Scale from: 300 to 840; more minutes equalled better outcome; CFB and double‐blind average values included · Patients with insomnia

1 finding from 1 review

Eszopiclone for insomnia 2018 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 2935 participants
Moderate

Early intervention (mobilization or active exercise) vs usual care

Adverse events Proportion of participants with one or more events, or proportion of intervention sessions where an event occurred (falls, accidental dislodgement of attachments, haemodynamic instability, oxygen desaturation or any other adverse ev... · critically ill, mechanically ventilated adults

1 finding from 1 review

Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit 2018 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 690 participants
Low

Information, feedback, and/or counselling vs information only or no intervention

Mean difference in time in sitting bouts lasting 30 minutes or more, short‐term · employees who sit at work

2 findings from 1 review

Workplace interventions for reducing sitting at work 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 28 participants
Low
Workplace interventions for reducing sitting at work 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Information, feedback, and/or counselling vs information only or no intervention

Mean difference in time in sitting bouts lasting 30 minutes or more, medium‐term · employees who sit at work

The review found no eligible studies for this question.

1 finding from 1 review

Workplace interventions for reducing sitting at work 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Multi‐component intervention vs no intervention

Mean difference in time in sitting bouts lasting 30 minutes or more, short‐term · employees who sit at work

1 finding from 1 review

Workplace interventions for reducing sitting at work 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 518 participants
Very low

Alternative desks and workstations vs sit‐desks

Mean difference in time in sitting bouts lasting 30 minutes or more, short‐term · employees who sit at work

2 findings from 1 review

Workplace interventions for reducing sitting at work 2018 · Cochrane Headline outcomes only
no estimate extracted
74 participants
Very low
Workplace interventions for reducing sitting at work 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Workplace policy changes vs alternate intervention or no intervention

Mean difference in time in sitting bouts lasting 30 minutes or more, short‐term · employees who sit at work

The review found no eligible studies for this question.

1 finding from 1 review

Workplace interventions for reducing sitting at work 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: intravitreal bevacizumab plus intravitreal steroid vs intravitreal steroid

Gain or loss of 10 or more letters visual acuity at 1 year · adults with centre‐involving diabetic macular oedema

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: intravitreal bevacizumab plus intravitreal steroid vs macular laser

Gain or loss of 10 or more letters visual acuity at 1 year · adults with centre‐involving diabetic macular oedema

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metabolomics vs non metabolomics

Multiple pregnancy · Women undergoing IVF/ICSI cycles

Metabolomics showed no clear difference in multiple pregnancy (presence of more than 1 gestational sac) compared with non metabolomics (low certainty).

1 finding from 1 review

Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies 2018 · Cochrane Headline outcomes only
OR 1.5 [0.7, 3.19]
2 studies · 180 participants
Low

Blue‐light filtering intraocular lenses (IOL) vs non blue‐light filtering IOL

BCVA: loss of 15 or more ETDRS letters · adults undergoing cataract surgery with IOL implantation

1 finding from 1 review

Blue‐light filtering intraocular lenses (IOLs) for protecting macular health 2018 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 63 participants
Very low